🇺🇸 Branched chain amino acid in United States

10 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Ammonia Increased — 1 report (10%)
  2. Decreased Appetite — 1 report (10%)
  3. Erythema — 1 report (10%)
  4. Feeling Abnormal — 1 report (10%)
  5. Hepatocellular Carcinoma — 1 report (10%)
  6. Malignant Neoplasm Progression — 1 report (10%)
  7. Nasopharyngitis — 1 report (10%)
  8. Palmar-Plantar Erythrodysaesthesia Syndrome — 1 report (10%)
  9. Skin Lesion — 1 report (10%)
  10. Stomatitis — 1 report (10%)

Source database →

Branched chain amino acid in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Branched chain amino acid approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Branched chain amino acid in United States?

Post Graduate Institute of Medical Education and Research, Chandigarh is the originator. The local marketing authorisation holder may differ — check the official source linked above.